Business
CareXM Completes CardioComm Solutions ECG Technology Integration for Full Service Remote ECG Patient Monitoring
Collaboration to Add Comprehensive Arrhythmia Monitoring Services Under CareXM's TouchPointCare T...
About this update from Cardiocomm Solutions, Inc.
[{"type":"text","content":"CareXM Completes CardioComm Solutions ECG Technology Integration for Full Service Remote ECG Patient MonitoringCollaboration to Add Comprehensive Arrhythmia Monitoring Services Under CareXM's TouchPointCare Telemedicine PlatformToronto, Ontario--(Newsfile Corp. - December 15, 2022) - CardioComm Solutions, Inc. (TSXV: EKG) (\"CardioComm\" or the \"Company\"), a global provider of consumer heart monitoring and electrocardiogram (\"ECG\") device and software solutions, confirms a technology integration agreement with Utah-based CareXM LLC. (\"CareXM\"), a provider of virtual care and patient engagement solutions for healthcare providers. Under the agreement CareXM has integrated ECG monitoring capabilities through their TouchPointCare telemedicine platform. CareXM has incorporated CardioComm's ECG viewer as an embedded technology in their TouchPointCare platform to enable patients and physician clients to view ECGs while recording and to replay ECGs prior to being uploaded for ECG reporting. Uploaded recordings will be processed by CardioComm's SMART Monitoring ECG service and securely transmitted in near real-time to the CareXM TouchPointCare platform where ECG reporting and patient care needs will be managed. Under the current deployment, patients will utilize the HeartCheck™ CardiBeat to collect their ECGs under prescribed patient care protocols. CareXM and CardioComm are examining the addition of 12 lead, Holter and arrhythmia/event monitoring devices and expanding the capabilities of the TouchPoinCare platform to offer comprehensive outpatient and ambulatory ECG monitoring. Sales and marketing of the ECG enabled TouchPointCare platform will be undertaken exclusively by CareXM. CardioComm will see revenue from the sales of the HeartCheck™ CardiBeat ECG devices as well as from ECG service and triaging fees.Through the addition of the GEMS™ technology, the TouchPointCare platform will be capable of recognizing multiple ECG devices with up to 12 leads of ECG recording and provide customers with more options in choosing a device of their preference. The HeartCheck™ CardiBeat will be the recommended device for self-directed and prescribed remote arrhythmia monitoring and all recorded ECGs will be passed through CardioComm's SMART Monitoring ECG service. The option for ECG triaging services to confirm the ...